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Metabolic profiling reveals 
potential metabolic markers 
associated with Hypoxia Inducible 
Factor-mediated signalling in 
hypoxic cancer cells
Emily G. Armitage1,†, Helen L. Kotze1, J. William Allwood2,‡, Warwick B. Dunn2,3,4,$, 
Royston Goodacre2 & Kaye J. Williams5
Hypoxia inducible factors (HIFs) plays an important role in oxygen compromised environments 
and therefore in tumour survival. In this research, metabolomics has been applied to study HIFs 
metabolic function in two cell models: mouse hepatocellular carcinoma and human colon carcinoma, 
whereby the metabolism has been profiled for a range of oxygen potentials. Wild type cells have 
been compared to cells deficient in HIF signalling to reveal its effect on cellular metabolism under 
normal oxygen conditions as well as low oxygen, hypoxic and anoxic environments. Characteristic 
responses to hypoxia that were conserved across both cell models involved the anti-correlation 
between 2-hydroxyglutarate, 2-oxoglutarate, fructose, hexadecanoic acid, hypotaurine, pyruvate 
and octadecenoic acid with 4-hydroxyproline, aspartate, cysteine, glutamine, lysine, malate and 
pyroglutamate. Further to this, network-based correlation analysis revealed HIF specific pathway 
responses to each oxygen condition that were also conserved between cell models. From this, 
4-hydroxyproline was revealed as a regulating hub in low oxygen survival of WT cells while fructose 
appeared to be in HIF deficient cells. Pathways surrounding these hubs were built from the direct 
connections of correlated metabolites that look beyond traditional pathways in order to understand 
the mechanism of HIF response to low oxygen environments.
Hypoxia inducible factors are heterodimeric transcription factors that can promote survival in low oxy-
gen environments and are prevalent in solid tumours. The most studied is HIF-1 which is known to 
regulate a multitude of genes and proteins. HIF-2 can similarly influence gene and protein expression 
however the effects of HIF-mediated signalling on the metabolome, the functional level many consider 
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to be most closely related to the phenotype, are less well characterised. HIFs consist of two subunits: the 
constitutively expressed β subunit and the oxygen labile α subunits that are subject to post translational 
modification and subsequent degradation in the presence of oxygen1. Under low oxygen conditions, 
degradation is inhibited and the α subunits translocate to the nucleus in order to complex with HIF-1β 2. 
The activated complex controls the regulation of genes containing hypoxia response elements (100–200 
genes)3.
HIF-1 is known to up-regulate genes encoding glucose transporters (Glut-1 and 3) in addition to a 
range of other glycolytic enzymes, including those controlling the rate of glycolytic flux (hexokinase, 
phosphofructokinase, pyruvate kinase and lactate dehydrogenase (LDH)4. HIF-1 also induces expression 
of monocarboxylate transporter-4 (MCT-4), which facilitates the metabolic co-cooperativity between 
aerobic and hypoxic cells5, whereby hypoxic cells generate and excrete lactate via up-regulated LDH and 
MCT-1 activity and the aerobic tumours cells utilise the lactate metabolism following uptake via MCT-15.
Both tumour suppressor inactivation and oncogene activation can contribute to HIF activity and have 
consequential effects on metabolism4. Lack of HIF-1 β subunit expression and consequential prevention 
of heterodimer formation and HIF function causes phenotypic alterations particularly with respect to 
metabolism6. For example, ATP content can be compromised by up to 80% with HIF-1 β deficiency. 
Most research concerning HIFs and its interaction with the metabolome has focused on glycolysis. 
Revealing the effects of HIF on the metabolome as a whole system has the potential to reveal metabolic 
pathways beyond glycolysis that are important in cancer phenotype and that are potential targets for 
cancer therapy.
The use of metabolomics based approaches in cancer research is growing and a range of applica-
tions in this field have been recently reviewed7. In this research metabolic profiling has been employed 
to discover HIF dependent (and independent) influences on regulation of the global metabolome in 
cancer by identifying metabolic signatures representative of HIF function in oxygen deprived environ-
ments. Intracellular extracts from cells without HIF function have been compared to wild type (WT) cell 
extracts (i) to observe which features are missing when HIF is not functional, (ii) to discover features 
that are added in low oxygen environments with a lack of HIF function and (iii) to discover features 
independent of HIF-function.
Three oxygen conditions have been compared (normoxia-21%, hypoxia-1% and anoxia-0%) in order 
to study the phenotypic responses of cells with and without functional HIF. Although the oxygen condi-
tions selected in this study are used by many to imitate normoxia, hypoxia and anoxia8, an initial study 
was undertaken to evaluate whether atmospheric (21%) oxygen is reflective in metabolic terms of expo-
sure to 5% oxygen which may be considered to be closer to the physiological level. Fourier transform 
infra-red (FT-IR) spectroscopy was used as a global metabolic fingerprinting method to confirm 21% 
oxygen as a valid condition to represent normoxia.
Following the determination of oxygen conditions, two models were used to investigate the impact 
of HIF-function on the metabolome under oxygen deprived conditions: human colorectal HCT 116 
and murine hepatoma HEPA-1 cells and derivatives lacking HIF-function via expression of a dom-
inant negative HIF-1α construct (HCT116 DN) or through lack of HIF-1β (HEPA-1 c4). Metabolic 
profiles of WT and HIF deficient cells have been analysed using gas chromatography-mass spectrome-
try (GC-MS). Human and murine models were employed in order to reveal conserved and differential 
effects of HIF-function on the cellular metabolome. Multi-level analysis of this data including univariate, 
multivariate and network-based correlation analysis has provided mechanistic insight into the role of 
HIF in global metabolism. For example, key metabolic hubs for WT and HIF deficient cells have been 
revealed allowing identification of potentially important enzyme activities driving HIF-dependent met-
abolic effects. The determination of hubs and key pathways that change in response to HIF function or 
oxygen treatment provides insight into the cellular response to hypoxic stress and potentially reveals 
targets for cancer therapy.
Results
FT-IR fingerprint validation of oxygen conditions. FT-IR spectroscopy was employed as a rapid 
screening method to evaluate whether the cellular metabolome observed under ambient atmospheric 
oxygen levels of 21% is reflective of that observed at more physiological levels of 5% oxygen and whether 
this was distinct from metabolic characteristics under oxygen deprivation. FT-IR spectroscopy was used 
to compare the intracellular fingerprints of HEPA-1 WT and C4 cells cultured at 21%, 5%, 1% or 0%. 
Details of the methodology for this are given in supplementary information. Figure 1 shows the scores 
plots of principal component (PC) 1 versus PC 2 for HEPA-1 WT and C4 cells; where in both cases 
there is a grouping of 21% and 5% samples that separate from the lower oxygen samples. This indicated 
that there was no significant difference between the profiles of cells cultured at 21% compared to 5% 
supporting that either could be used to represent the normoxic condition and validating the use of 21% 
oxygen in subsequent metabolic fingerprinting experiments.
Metabolic profiling. Metabolic profiling utilising GC-MS was performed to determine the effect 
of HIF-function on the metabolism of cells exposed to different oxygen conditions (normoxia: 21%, 
hypoxia: 1%, anoxia 0%). From the analysis of both WT and HIF deficient cells, a total of 42 and 41 peaks 
passed our protocol tests and had relative standard deviations (RSDs) lower than 30% in the GC-MS 
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profiling of QC samples in the HCT 116 and HEPA-1 models respectively. These were identified to MSI 
guidelines as (referred to in methods) and are listed in Table 1 of supplementary information. Heat maps 
of peak intensities were generated for each model and are shown in Fig. 2 of supplementary information. 
Peak numbers are in accordance to the order in CVA and in table 1 of the supplementary information. 
Additionally, data are supplied as supplementary information.
An initial PCA was performed on all samples from each cell line including QC samples to confirm 
that the batch matching process was successful. The plot generated from this analysis of the HCT 116 
cell line is shown in Fig. 2, where the QC samples were observed to fall in the centre of the PCA plot 
and amongst other data points suggesting the data were correctly pre-processed. This plot also shows that 
the variation in metabolism is greater affected by oxygen level than by HIF: it is not possible to separate 
WT and DN cells by PCA.
Canonical variates analysis (CVA) was performed in order to identify individually how WT and 
HIF deficient cells respond to the range of oxygen treatments. This was conducted separately for HCT 
116 WT samples, HCT 116 DN samples, HEPA-1 WT samples and HEPA-1 C4 samples. In all cases a 
gradient between oxygen tensions could be identified with a clear separation in CV 1 between normoxic 
samples and low oxygen samples (Fig.  3). These separations were caused by different anti-correlations 
between metabolite features that appeared to be controlled by HIF. The loadings from these analyses were 
assessed in turn to identify features of normoxia and low oxygen samples in each plot which were then 
compared to each other to find similarities as a function of oxygen exposure and as a function of HIF 
presence or absence in each cell model. The results from this are summarised in Table 1.
A direct comparison between cells with and without functional HIF was made by performing CVA on 
hypoxic WT and DN cells then on WT and C4 cells. It was hoped that understanding the multi-component 
variation in the metabolome as a response to hypoxia with respect to HIF activity would lead to eluci-
dating the role of HIF in cancer cell metabolism, especially as there are oxygen gradients within solid 
tumour. Furthermore, comparing HCT 116 and HEPA-1 analyses identified the conserved responses of 
WT and HIF deficiency. The results from this CVA are shown in Fig. 4.
Network-based correlation analysis of metabolites. Correlation analysis was performed 
metabolite-by-metabolite in a pair-wise fashion and significant differences in correlation coefficients 
were identified in the following comparisons for each cell model: normoxia versus hypoxia, normoxia 
versus anoxia and hypoxia vs. anoxia. Following this, comparisons were made between models to identify 
conserved correlations of HIF-1 activity in both cell models. Since the two cell models were of different 
species origin, these correlations are likely to be the most conserved and potentially the key regulators 
of HIF associated metabolism. In the case of HIF deficient cells, they represent the most conserved 
regulations as compensation to low oxygen survival when HIF is not functional. In both HCT 116 and 
HEPA-1 models, there were two conserved correlation differences in WT cells between normoxia and 
hypoxia: between 4-hydroxyproline and glycerol and between 4-hydroxyproline and tyrosine/tyramine. 
In HIF deficient cells, there was one correlation difference between normoxia and hypoxia: between 
fructose and citrate. In both HCT 116 and HEPA-1 models, there was one conserved correlation dif-
ference in WT cells between normoxia and anoxia: between 4-hydroxyproline and methionine. In HIF 
deficient cells, there was also one correlation difference between normoxia and anoxia: between fructose 
and citrate. There were no correlation differences between hypoxia and anoxia in WT cells, however in 
HIF deficient cells there were two: between fructose and glutamate and between fructose and putrescine. 
Figure 1. Principal components analysis (PCA) scores plots of PC 1 versus PC 2 for intracellular FT-IR 
metabolic fingerprints of HEPA-1 wild type (WT) (left) and C4 (right) cells exposed to 21% oxygen, 1%, 
5% and 0% oxygen. In both cell lines, intracellular profiles from 21% and 5% oxygen group and separate 
from 1% and 0% highlighting the similarity between 21% and 5%.
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Metabolite HCT 116: loading common between WT and DN HEPA-1: loading common between WT and C4
4-aminobutyrate normoxia
4-hydroxyproline normoxia
Allose/Mannose/Galactose /Glucose (1) * *
Allose/Mannose/Galactose /Glucose (2) * *
Allose/Mannose/Galactose /Glucose (3) normoxia
2-hydroxyglutarate low oxygen
2-oxoglutarate normoxia* normoxia*
Aspartate (1) normoxia
Aspartate (2) normoxia* normoxia*
Beta-alanine normoxia
Citrate normoxia* normoxia*
Creatinine low oxygen
Cysteine normoxia
Erythronate /Threonate low oxygen* low oxygen*
Fructose (1) * *
Fructose (2) normoxia
Fructose / Sorbose (1) low oxygen
Fructose / Sorbose (2) low oxygen* low oxygen*
Glutamate normoxia low oxygen
Glutamine normoxia* normoxia*
Glycerol low oxygen* low oxygen*
Glycerol-3-phosphate low oxygen
Glycine low oxygen
Hexadecanoic acid * *
Hypotaurine low oxygen* low oxygen*
Lactate low oxygen* low oxygen*
Leucine N/A
Lysine low oxygen
Malate normoxia
Malonate low oxygen* low oxygen*
Methionine low oxygen* low oxygen*
Norleucine low oxygen* low oxygen*
Phosphate low oxygen* low oxygen*
Phosphocreatinine N/A
Putrescine normoxia* normoxia*
Pyroglutamate normoxia
Pyruvate normoxia
Scyllo-/Myo-inositol * *
Octadecenoic acid * *
Threonine low oxygen* low oxygen*
Tyramine/Tyrosine low oxygen
Tyrosine normoxia* normoxia*
xylitol/Ribitol low oxygen N/A
Table 1. Comparison of the loadings from canonical variate analysis (CVA) of all 3 oxygen conditions. CVA was 
performed for HCT 116 wild type (WT) samples, HCT 116 dominant negative (DN) samples HEPA-1 WT samples 
and HEPA-1 C4 samples (Fig. 3a–d). Metabolites labelled ‘normoxia’ were identified in the loadings as being features 
of normoxia that were common between WT and HIF-1 deficient cells, while metabolites labelled ‘low oxygen’ were 
identified in the loadings as being features of low oxygen that were common between WT and hypoxia inducible 
factor 1 (HIF-1) deficient cells. Un-labelled metabolites represent HIF-1 mediated responses to oxygen since the 
loadings were not common between WT and HIF-1 deficient cells. Metabolites marked with an asterisk (*) indicate 
cell line similarities such that the same behaviour was observed in both HCT 116 and HEPA-1cell lines.
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The shortest paths between differently correlated metabolites were calculated and these pathways are 
depicted in Fig. 5.
Figure 2. Principal components analysis (PCA) on all HCT 116 metabolic profiles analysed using gas 
chromatography-mass spectrometry (GC-MS). The quality control (QC) samples formed from pooling 
small quantities from each sample displayed on the plot fall approximately in the middle. WT = wild 
type; DN = dominant negative.
Figure 3. Canonical variates analysis (CVA) scores plots for (a) HCT 116 wild type (WT), (b) HEPA-1 WT, 
(c) HCT 116 dominant negative (DN) and (d) HEPA-1 C4 samples comparing all 3 oxygen conditions. Each 
CVA model was built using 8 principal components (PCs) collectively accounting for between 80% and 
90% of the total explained variance from each analysis. In all cases the greatest separation in the data was 
between normoxic samples and low oxygen samples in canonical variate (CV) 1.
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Discussion
Intracellular extracts from cells without HIF function have been compared to WT cell extracts (i) to 
observe which features are lost when HIF is not functional, (ii) to discover features that are added in 
low oxygen environments with a lack of HIF function and (iii) to discover features independent of 
HIF-function. Cancer therapy based on perturbing pathways associated with identified metabolites will 
require both the knowledge of how the system functions in the presence of HIF and the mechanisms 
employed in the absence of HIF. Aside from revealing potential metabolic targets for future cancer ther-
apy, revealing markers of HIF metabolism could lead to a better understanding of the phenotype and 
may enable more successful diagnosis and prognosis of cancer in patients. Screening tumour extracts for 
relevant signatures determined for each oxygen level in these in vitro experiments could help identify the 
level of hypoxia in the tumour. The present experiments were not designed to identify the relative con-
tributions of HIF-1 or 2 to metabolic phenotype. From previous work HIF-1 appears the predominant 
driver of hypoxia-mediated responses in both models used in the current study (unpublished observa-
tions). However the nature of the modifications within the derivative cells renders both HIF-1 and 2 
non-functional giving a more global impact of HIF-signalling on metabolic regulation.
CVA revealed metabolic signatures that could be attributed to cellular response to lowering oxygen, 
seemingly controlled or not by HIF and signatures that revealed the same phenotypic responses, irre-
spective of cell line. From Table  1, it is possible to subdivide metabolites into four types of metabolic 
signatures: features of oxygen treatment irrespective of HIF and conserved between cell lines; features 
of oxygen treatment irrespective of HIF but dependent on cell line; features that were HIF specific but 
cell line dependent and finally features that were HIF specific in both cell lines. Many responses were 
conserved between HCT 116 and HEPA-1 cells which provided confidence in recognising the results as 
HIF related metabolites.
Figure 4. Canonical variates analysis (CVA) of hypoxic (1% oxygen) samples in the HCT 116 (a,b) and 
HEPA-1 (c,d) cell models. In each case the CVA models were built using principal components (PCs) 1–12 
accounting for approximately 90% or the total explained variance. The distributions of samples in canonical 
variate (CV) 1 for each cell model are represented as bar charts (a,c) where the number of samples per bin 
is shown. The loadings for CV 1 for each cell model are shown (b,d). The peak number refers to unique 
metabolites and follows the same order as in Table 1 of supplementary information.
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The direct comparison between cells with and without functional HIF made by performing CVA on 
hypoxic WT and DN cells or WT and C4 cells for HCT 116 and HEPA-1 cell models respectively enabled 
evaluation of the impact of HIF on metabolism in hypoxia. Although the loadings (Fig. 4b,d) demon-
strated considerable variance between the two cell models, there were similarities in the anti-correlation 
between metabolites causing the separation between WT and HIF deficient cells in each. The positive 
loadings and features of WT cells for each cell line consisted of 2-hydroxyglutarate, 2-oxoglutarate, fruc-
tose, hexadecanoic acid, hypotaurine, pyruvate and octadecenoic acid which were anti-correlated with 
4-hydroxyproline, aspartate, cysteine, glutamine, lysine, malate and pyroglutamate (which is a cyclisation 
product of glutamate during the chemical derivatisation process) in the negative loadings. It is likely that 
2-hydroxyglutarate, 2-oxoglutarate, fructose, hexadecanoic acid, hypotaurine, pyruvate and octadecenoic 
acid are associated with HIF signalling and that these targets are conserved across species. In addition to 
pyruvate, 2-oxoglutarate and 2-hydroxyglutarate are all connected to central carbon metabolism via the 
TCA cycle. Figure 6 shows a schematic for how these three metabolites interact. Since they are affected by 
the presence or absence of HIF, this provides some evidence that HIF targets central carbon metabolism, 
more specifically through the replenishment of TCA intermediates through the process of anaplerosis.
It is of interest that 2-hydroxyglutarate and 2-oxoglutarate are elevated in a HIF-dependent fash-
ion. 2-hydroxyglutarate is commonly described as an “onco-metabolite” through apparent correla-
tions of enhanced abundance and tumourigenecity. Much emphasis has been placed on generation of 
2-hydroxyglutarate via a mutated form of isocitrate dehydrogenase-1 (IDH1-R132X) which is a common 
feature of gliomas9. However the HCT 116 model used in these studies has WT IDH110. As highlighted 
in Fig.  6, this perhaps implicates 2-hydroxyglutarate dehydrogenase (KEGG enzyme code 1.1.99.2)11. 
This could be via direct or indirect mechanisms. 2-hydroxyglutarate has been implicated as an inhibitor 
of the prolyl hydroxylase (PHD) enzymes that are required for degradation of the HIF-α subunits whilst 
2-oxoglutarate is required for PHD activity. Modifications in the relative balance of the two could con-
ceivably modify HIF-signalling. Further complexity arises with the recent observation of non-enzymatic 
oxidation of 2-hydroxyglutarate to 2-oxoglutarate12. Although the physiological relevance of this process 
is yet to be proven, it is likely that both enzymatic and non-enzymatic reactions contribute to overall 
metabolite balance which can potentially both influence HIF-function and be influenced by the met-
abolic environment promoted by HIF. Two very recently published articles, confirm our observations 
that hypoxia induces cellular production of 2 hydroxyglutarate13,14. Mechanisticially, 2-hydroxyglutarate 
Figure 5. Network-based correlation analysis for HCT 116 and HEPA-1 cell models. Conserved 
correlation differences between normoxia, hypoxia and anoxia were mapped onto the EHMN 
reconstruction using a shortest path analysis described previously13. Pathways are coloured according 
to which oxygen levels correlation differences occurred and are presented for a) WT cells and b) HIF-1 
deficient cells of both models. KEGG compound and reaction identifiers are indicated. Tyrosine and 
tyramine are contained in a box to denote that this metabolite was not definitively identified in the GC-MS 
analysis.
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production appeared dependent on promiscuous substrate use by LDH-A. The authors found HIF to 
be sufficient but not necessary for 2-hydroxyglutarate production. This observation aligns with how 
dependent LDH-A expression is on HIF-activity within the cell models used. LDH-A is expressed in a 
HIF-dependent manner in both of the models used in our studies (Hepa-1WT and c4 data published 
in Golinska et al. 201115, HCT 116 WT and DN unpublished observations, Cowen RL and Williams 
KJ). This is exploited in the HIF-activity reporter system we use (driven by an LDH-A-promoter) and 
explains the HIF-dependency of 2-hydroxyglutarate production in these model systems.
Hexadecanoic acid and octadecenoic acid, found in WT cells, are both features of multiple metabolic 
pathways including fatty acid (FA) biosynthesis (KEGG pathway ko00061). Figure 7 shows a schematic 
for FA biosynthesis where hexadecanoic acid and octadecenoic acid are endpoints. FA biosynthesis was 
the other main pathway highlighted by comparing WT and HIF deficient cells, suggesting a role for HIF 
in regulating this metabolic pathway.
It is clear from CVA that the mechanisms of cellular response to hypoxia and the role HIF plays in 
this response is complex. Although some relationships could be made to existing pathways it is diffi-
cult to interpret metabolomics results on this level. Network-based correlation analysis offered a more 
complete insight into the cellular responses to lowering oxygen that were different in the case of HIF 
functionality or deficiency. Using network-based correlation analysis reveals potential pathway targets 
that are constructed not from the traditional schematics of pathways but from the direct connections 
between metabolites that can cross many 'traditional' pathway boundaries4,16. Further to revealing new 
target pathways, this method allows the clear identification of 'hub' metabolites that appear to play a 
central role in the control of cellular response to lowering oxygen. From the current studies, when HIF 
is functional, 4-hydroxyproline appears as a hub metabolite, while fructose appears as a hub metabolite 
when HIF is deficient. In the case of 4-hydroxyproline, its associated pathways may be a feature of sur-
vival in hypoxia or anoxia relative to normoxia. The correlation between fructose and citrate appeared 
to be of importance in low oxygen survival (correlated in hypoxia and anoxia relative to normoxia), 
Figure 6. The interaction between pyruvate, 2-oxoglutarate and 2-hydroxyglutarate and central carbon 
metabolism. 2-hydroxyglutarate dehydrogenase (KEGG enzyme 1.1.99.2) catalyses a reversible reaction 
between 2-oxoglutarate and 2-hydroxyglutarate. All 3 metabolites feed into the tricarboxylic acid (TCA) 
cycle.
Figure 7. Fatty acid (FA) biosynthesis. Hexadecanoic acid and octadecenoic acid are two of the end 
points of FA biosynthesis that metabolises acetyl-coA via malonyl-coA. Acetyl-CoA carboxylase alpha 
(KEGG enzyme 6.4.1.2).
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however when comparing hypoxia and anoxia, a different pathway between fructose and putrescine was 
highlighted. Figure 5 shows the pathway responses to low oxygen surrounding these hubs. Irrespective 
of oxygen level, deprivation, KEGG reaction R01252 is the key responding reaction that involves pro-
line hydroxylase (KEGG code 1.14.11.2), the activity of which could be positively influenced by the 
2-hydroxyglutarate/2-oxoglutarate changes also observed in WT cells. In contrast the key reactions sur-
rounding fructose as the hub metabolite in HIF deficient cells are R00876 and R01140. These reactions 
involve hexokinase (2.7.1.1), isoform 2 of which (HK2) is strongly implicated in driving high glycolytic 
flux, ribonucleotide synthesis via the pentose phosphate pathway and maintenance of TCA intermediates 
via anaplerosis17, consistent with the metabolite and network correlations observed. Paradoxically both 
HK1 and HK2 are recognised transcriptional targets of HIF-118,19, yet here, in the absence of HIF activity, 
a specific reliance on this enzyme is revealed.
In conclusion, a range of metabolites have been discovered from GC-MS analysis of WT and 
HIF-deficient HCT 116 and HEPA-1 cells exposed to differing levels of oxygenation that reflect both 
HIF dependent and independent processes often conserved across species.
Some of the most interesting HIF-related metabolites discovered from multivariate analysis using 
CVA were 2-hydroxyglutarate, 2-oxoglutarate, hexadecanoic acid, hypotaurine, pyruvate and octadece-
noic acid. These findings warrant investigation of the role of HIF in hypotaurine metabolism, butanoate 
metabolism, FA biosynthesis and biosynthesis of unsaturated FAs. Network-based correlation analysis 
revealed 4-hydroxyproline to be a regulated hub in low oxygen survival of WT cells of both models while 
fructose appeared to be a hub in HIF deficient cells. This analytical method also offered a complementary 
way of revealing a mechanistic basis of how HIF function influences cancer metabolism.
Materials and Methods
Cell lines. HEPA-1 WT, HIF-1β -deficient HEPA-1 C4, HCT 116 WT and HCT 116 cells expressing a 
dominant negative (DN) HIF-1α construct are described in previous publications: development and val-
idation of HEPA-1 C4 is given in Hoffman et al. (1991)20, Maxwell et al. (1997)21 and Troy et al. (2005)6, 
where HIF-1β was found not to be expressed in these cells. The HIF-1α DN construct is detailed in 
Brown et al. (2006)22 and the HCT116-DN model in Roberts et al. (2009)8.
Experimental conditions for growth. For each sample obtained for metabolic profiling by GC-MS, 
cells were seeded in exponential phase at 1 × 106 cells/mL in RPMI 1640 (Gibco BRL, Paisley, UK) sup-
plemented with 10% undefined foetal calf serum (FCS) (Labtech International, East Sussex, UK) and 
2 mM glutamine (Sigma-Aldrich, Dorset, UK) into a 10 cm2 Petri dish (Falcon, Runcorn, UK). They 
were maintained in normoxia (95% air and 5% CO2 at 37 °C and 95% relative humidity) for 24 h in the 
conditions described for routine culture. For exposure to 24 h oxygen treatments, samples were divided 
into three groups: 30 replicates to remain in normoxia, 30 replicates to be exposed to hypoxia (1% oxy-
gen) and 30 replicates to anoxia (0% oxygen). The hypoxic condition was achieved using a closed vessel 
though which gas containing 1% O2, 5% CO2 balanced with N2 was flowed23. The anoxic condition uti-
lised a gloved chamber (Bactron anaerobic chamber, Sheldon Manufacturing, Cornelius, Oregon, USA) 
in which all parameters other than oxygen were comparable to the other two conditions and all necessary 
sample preparation and incubation was done in this system. Residual oxygen was removed by flowing 
supply gas over a palladium catalyst. Cell harvesting in each experiment was conducted in normoxia (for 
normoxic samples) and in anoxia for hypoxic or anoxic samples whereby the gas taps were locked on the 
hypoxia chamber after the removal of the hypoxic gas inlet to prevent re-oxygenation of hypoxic samples.
Validation of oxygen treatments. Oxygen conditions were chosen to be 21% representing normoxia, 
1% representing hypoxia and 0% representing anoxia. Fourier transform infrared (FTIR) -spectroscopy 
was employed as a fingerprinting technique in the selection of oxygen conditions (particularly in the 
validation of selecting 21% oxygen as the condition to represent normoxia, rather than 5% that could be 
the more physiologically relevant level, but that was not observed to differ experimentally from 21%). 
Details of this assay and the results are given in supplementary information.
Samples for metabolic profiling by GC-MS were collected over 4 batches for HCT 116 cells and 4 
batches for HEPA-1 cells, where each batch contained an equal number of WT and HIF-1 deficient cells 
exposed to normoxia, hypoxia or anoxia. In total there were 6 experimental groups per cell model (WT 
and HIF-1 deficient forms exposed to normoxia, hypoxia or anoxia).
In every batch, the level of HIF-1 transcriptional activity was measured for a sample in each experi-
mental group using a luciferase reporter-based assay23. This was performed as a quality check to ensure 
HIF-1 transcriptional activity consistency between batches of samples collected for GC-MS analysis. In 
all cases, HIF-1 activity was shown to increase in hypoxic and anoxic WT cells compared to normoxic 
WT cells that was not the case in HIF-1 deficient cells. The methods and results from this can be found 
in supplementary information.
Metabolite extraction. For metabolite extraction, extracellular medium was first decanted and cells 
were washed three times with 1 mL PBS at room temperature. Immediate quenching of metabolism 
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was achieved by first adding 1 mL methanol (maintained at − 48 °C) to each sample. Subsequently, cell 
scrapers were used to remove the adherent cells from the culture surface and the cell suspension was 
transferred into 1.5 mL Eppendorf tubes (Fisher Scientific, Loughborough, UK). A series of 3 freeze-thaw 
cycles using liquid nitrogen was performed for all samples followed by centrifugation at 17000 × g for 
15 min. Supernatants were transferred into new 1.5 mL Eppendorfs and the volume to be lyophilised 
was normalised according to the weight of the dry pellet following extraction for intracellular sam-
ples (achieved using HETO VR MAXI with RVT 4104 refrigerated vapour trap (Thermo Life Sciences, 
Basingstoke, UK)). Remaining supernatants after normalisation were used to generate QCs which con-
tained an equal proportion (150 μ L) of each sample. Supernatants for both the samples and QCs were 
lyophilised after the addition of 100 μ l of an internal standard (0.18 mg/ml succinic d4 acid in water).
Sample preparation for GC-MS. Prior to metabolic profiling by GC-MS analysis, all samples 
were chemically derivatised using a two-stage process: the addition of 50 μ L of a 20 mg/mL solution 
of O-methoxylamine in pyridine followed by vortex mixing and heating at 60 °C for 30 min, and the 
addition of 50 μ L of N-methyl-N-trifluoroacetamide followed by vortex mixing and heating at 60 °C for 
30 min. Subsequently, debris was pelleted through centrifugation at 17000 × g for 10 min and finally, 20 μ L 
of a retention index marker solution containing 0.3 mg/mL n-decane, n-dodecane and n-pentadecane, 
n-docosane and n-nonadecane in pyridine was added. The resulting supernatants were analysed by 
GC-MS.
The GC-MS instrument setup has been previously described24, and involves an Agilent 6890 GC 
(Agilent Technologies, Stockport, U.K.) coupled to a LECO Pegasus III (Leco Corp., St. Joseph, MO) 
EI-ToF-MS. Data acquisition followed a previously optimised sequence25: starting with a derivatisation 
blank, followed by five QC samples, then by five samples and one QC, repeatedly until the end of the 
analysis. Samples were injected at volumes of 2 μ L and the total analysis duration for a single sample was 
25 min. The temperature was 70 °C for 4 min and increased by 20 °C every min until 300 °C, which was 
subsequently maintained for a further 4 min.
All data were pre-processed using the ChromaTOF v3.25 software package. From a set of samples 
representative of all sample classes, the mass spectrum and retention index of all unique metabolites 
were exported to a reference table. This reference table was then used to match metabolites in all sam-
ples, where it was reported if a mass spectral match between the reference table and the sample peak 
was greater than 70% and the retention index deviation between them was less than 10. All data were 
normalised to the peak area of the internal standard (peak area metabolite/peak area internal standard). 
These data were exported as ‘.csv’ files for subsequent data analysis.
By matching the mass spectrum and retention index to those present in an in-house mass spectral 
library constructed with data acquired from authentic chemical standards, it was possible to identify 
a proportion of detected metabolites. A mass spectral match greater than 80% and a retention index 
match ± 20 provided a definitive identification26. For instances where a definitive identification (MSI 
level 1) to our in-house library could not be made, the mass spectrum was searched against other mass 
spectral libraries. For example, the National Institute of Standards and Technology (NIST05) data-
base of retention data for non-polar and polar stationary phases27 and the publically accessible Golm 
Metabolome Database of mass spectral libraries28 were used to identify metabolites putatively where 
a match greater than 80% was observed (MSI level 2). The level of identification reported was applied 
according to reporting guidelines as described by the MSI29.
Data treatment. A previously optimised method for data-pre-processing, involving control of met-
abolic features with excessive drift in signal25, was performed as follows: the RSD of each detected fea-
ture was calculated across all QC samples and for features, where in cases that the RSD exceeded 30%, 
that feature was removed from the whole data set. QCs were also used in signal correction within and 
between analytical blocks. For this quality control based robust LOESS (locally estimated scatter-plot 
smoothing) signal correction (QC-RLSC) was applied25. This process was performed after feature iden-
tification and before analysis of GC-MS data.
Pre-processed data were exported for univariate and multivariate data analysis in Matlab as a data 
matrix (m × n) where m denoted metabolite features and n denoted sample. Values were chromato-
graphic peak areas included for each feature detected in each sample. Prior to data analysis, outliers were 
identified within each experimental group as values greater than 2.5 standard deviations away from the 
mean for that metabolite in that group and were subsequently replaced by the mean30.
All data analyses were implemented using the Statistics Toolbox in Matlab. Data were observed to 
fit an approximately normal distribution after log transformation and therefore parametric tests were 
applied. A two-way analysis of variance (ANOVA) was employed to identify metabolites that differed 
significantly due to oxygen level, to HIF-1 presence or absence or due to an interaction between oxygen 
and HIF-1. Since many metabolites were being tested in parallel a false discovery test31, using α = 0.1 
was applied to control the critical p-value for rejecting the null hypothesis that there was no significant 
difference between oxygen levels and HIF-1 presence or absence. Box plots were generated for significant 
p-values < 0.05 that passed the false discovery test.
The first method for multivariate analysis was principal components analysis (PCA). Spectra were 
scaled by autoscaling32. After PCA, multivariate analysis was extended to canonical variates analysis 
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(CVA) whereby PCA was performed and a number of PCs were used along with the experimental group 
structure to build a model for maximising the between-group variance while minimising the within-group 
variance. This was performed without exceeding the number of PCs that additively described 95% of the 
total variance in the data in order to reduce the likelihood of over fitting which can invalidate the model.
Network-based correlation analysis was performed following our recently published method16. Briefly, 
Pearson correlation analysis was performed metabolite-by-metabolite in a pair-wise fashion and signif-
icant differences in correlation coefficients were identified in the following comparisons for each cell 
model; normoxia versus hypoxia, normoxia versus anoxia and hypoxia vs. anoxia. Since the number of 
samples exceeded 27, the difference in correlation coefficients in each comparison was considered sig-
nificant when it exceeded 0.407, when at least one correlation had an absolute value < 0.7. Finally the 
shortest paths between differently correlated metabolites were calculated in Matlab using the Edinburgh 
human metabolic network (EHMN)33.
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